Close Menu

NEW YORK (GenomeWeb) – In a study published online today in Science Translational Medicine, researchers from the UK and the US presented evidence that circulating tumor DNA can be used to track minimal residual disease and provide relapse clues in individuals treated for breast cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.